Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|December 30, 2021
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk AnalysisShuang Sun, Yu Men, Jingjing Kang, et al.
Leukemia & Lymphoma|March 20, 2024
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphomaLin-Rui Gao, Xinyue Wang, Yunpeng Wu, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapyLin-Rui Gao, Chen Li, Weiming Han, et al.
Journal of the National Cancer Center|September 16, 2024
Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysisJingnan Wang, Xin Liu, Yunpeng Wu, et al.
Frontiers in Immunology|August 20, 2025
Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patientsYirui Zhai, Yefan Zhang, Fan Wu, et al.
Thoracic Cancer|November 28, 2020
Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical marginsMeng Yuan, Yu Men, Jingjing Kang, et al.
Cancer Letters|March 21, 2024
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysisJing Yang, Xin Liu, Qiu-Zi Zhong, et al.
Cancer Medicine|April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single CenterLingxia Xin, Zhiyu Li, Yirui Zhai, et al.
Frontiers in Oncology|September 28, 2020
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II TrialXin Wang, Xiaolin Ge, Xiaomin Wang, et al.
JAMA Network Open|May 17, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical TrialXin Wang, Weiming Han, Wencheng Zhang, et al.
Pageof 7